rs397517930
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PM5PP5
The NM_174878.3(CLRN1):āc.142A>Gā(p.Asn48Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N48K) has been classified as Pathogenic.
Frequency
Consequence
NM_174878.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLRN1 | NM_174878.3 | c.142A>G | p.Asn48Asp | missense_variant | 1/3 | ENST00000327047.6 | NP_777367.1 | |
CLRN1 | NM_001195794.1 | c.142A>G | p.Asn48Asp | missense_variant | 1/4 | NP_001182723.1 | ||
CLRN1 | NM_001256819.2 | c.142A>G | p.Asn48Asp | missense_variant | 1/4 | NP_001243748.1 | ||
CLRN1 | NR_046380.3 | n.161A>G | non_coding_transcript_exon_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLRN1 | ENST00000327047.6 | c.142A>G | p.Asn48Asp | missense_variant | 1/3 | 1 | NM_174878.3 | ENSP00000322280.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251460Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135902
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727240
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
Retinal dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jul 31, 2019 | - - |
Usher syndrome type 3 Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 06, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 26, 2012 | Variant classified as Uncertain Significance - Favor Pathogenic. The Asn48Asp va riant in CLRN1 has been previously identified by our laboratory in one individua l with clinical features of Usher syndrome; however this individual also carrie d two variants on another gene that were likely responsible for the disease. It has not been reported in the literature or in large population studies. Another variant (Asn48Lys) affecting the same amino acid residue has been identified in individuals with Usher syndrome type III in several families of Jewish ancestry (Fields 2002, Herrera 2008). In addition, in vitro studies have shown that the Asn48Lys variant impacts normal protein function through the disruption of N-gl ycosylation (Isosomppi 2009, Tian 2009), suggesting that the Asn48 residue is in tolerant to variation. However, without additional data, it cannot be determined whether the Asn48Asp variant will have the same impact on the protein as the As n48Lys variant. Computational tools (amino acid properties, conservation, AlignG VGD, PolyPhen2, SIFT) do not provide strong support for or against pathogenicity . In summary, the clinical significance of this variant cannot be determined wit h certainty; however because the variant affects the same residue as another pat hogenic missense variant, we would lean towards a more likely pathogenic role. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2022 | This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 48 of the CLRN1 protein (p.Asn48Asp). This variant is present in population databases (rs397517930, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of retinitis pigmentosa (Invitae). ClinVar contains an entry for this variant (Variation ID: 48143). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Asn48Lys amino acid residue in CLRN1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12080385, 14569126, 22787034). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at